Assistant Professor of Strategy
Ashvin Gandhi conducts his research predominantly at the intersection of industrial organization and health economics. He is particularly interested in how firm strategy interacts with health care policy and regulation. His current work asks what would happen if the United States were to regulate pharmaceutical prices to be lower than in other countries. He finds that the dominant effect of such a reference pricing policy could influence drug companies to raise prices in other countries rather than lower them in the U.S.
Reliance on part-timers raises headcounts and dangers to patients
Higher morbidity found where fewer staffers are vaccinated against COVID-19
Payroll data allows researchers to finally build an accurate and meaningful measurement
But in uncompetitive markets, the financial owners cut staff
Rate of spread in the surrounding community was a bigger indicator of risk
When beds are limited, turning away the sickest and poorest boosts margins